MYLAN
Quick facts
Marketed products
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE · Other
- Cystagon · Metabolic
Cystagon works by binding to cystine and forming a disulfide bond, effectively removing cystine from the body. - Denavir · Infectious Disease
Denavir works by inhibiting the DNA polymerase enzyme of the herpes virus, preventing it from replicating and causing infection.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about MYLAN
What are MYLAN's marketed drugs?
Top marketed products include EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE, Cystagon, Denavir.
Related
- EFAVIRENZ, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE · Other
- Cystagon · Metabolic
- Denavir · Infectious Disease
- Sector hub: All tracked pharma companies